Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+0.15%
EPS
+342.0%
Free cash flow
+220.1%
Total debt
−39.4%

Quarter to September 2026, against a year earlier

151.46 0.69 −0.45%
Market cap
$6.5B
P/E
18.2×
Fwd P/E
37.4×
Dividend yield
0.90%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
15.04 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.30 2.45 2.49 2.73
P/FCF ratio
36.34 103.95 29.65 3,766.02
P/Operating CF
53.88 60.09 113.45 (147.10)
P/B ratio
1.79 1.90 1.72 1.74
EV/Sales
2.83 3.56 3.57 3.87
EV/EBITDA
24.89 31.34 29.13 25.63
EV/FCF
44.67 151.15 42.57 5,330.95
Current Ratio
2.01 2.60 2.55 2.54
Net Debt/EBITDA
0.00 20.20 30.61 (30.04)
Debt/Equity
0.46 0.97 0.85 0.85
Earnings Yield
6.65% (18.37%) (19.06%) (16.83%)
Free Cash Flow Yield
2.75% 0.96% 3.37% 0.03%
Free Cash Flow per Share
1.80 1.79 0.63 (0.01)
Book value per Share
84.22 66.68 69.69 70.03
Free Cash Flow
74.66 77.86 27.87 (0.65)
EV/EBIT
11.41 180.68 121.13 65.12
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026